SFX by Ex Libris Inc.

Title:	Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Source:	Organic Process Research & development [1083-6160] Chemburkar, Sanjay yr:2000

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bauer, J. "Ritonavir: An extraordinary example of conformational polymorphism." Pharmaceutical Research 18.6 (2001): 859-66.
description	2.	Morissette, Sherry L. "Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization." Proceedings of the National Academy of Sciences of the United States of America 100.5 (2003): 2180-2184.
description	3.	Ishida, T. "Physicochemical properties of crystalline forms of ethynylestradiol solvates: comparison of thermal behavior with x-ray crystal structure." Journal of pharmaceutical sciences 78.4 (1989): 274-422.
description	4.	Wang, Perry G. "A high-throughput liquid chromatography/tandem mass spectrometry method for simultaneous quantification of a hydrophobic drug candidate and its hydrophilic metabolite in human urine with a fully automated liquid/liquid extraction." Rapid communications in mass spectrometry 20.22 (2006): 3456-3464.
description	5.	Panina, N. "Crystal structure prediction of organic pigments: quinacridone as an example." Journal of applied crystallography 40.1 (2007): 105-114.
description	6.	Morissette, Sherry L. "High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids." Advanced Drug Delivery Reviews 56.3 (2004): 275-300.
description	7.	Chen, X. "Reactivity differences of indomethacin solid forms with ammonia gas." Journal of the American Chemical Society 124.50 (2002): 15012-15019.
description	8.	Datta, S. "Crystal structures of drugs: Advances in determination, prediction and engineering." Nature reviews. Drug discovery 3.1 (2004): 42-57.
description	9.	Moghimipour, E. "Preparation and characterization of dexamethasone microemulsion based on pseudoternary phase diagram." Jundishapur Journal of Natural Pharmaceutical Products 8.3 (2013): 105-12.
description	10.	Choksi, A. "Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer-dexamethasone conjugates with dexamethasone-liposomes." International journal of pharmaceutics 449.1-2 (2013): 28-36.
description	11.	Kim, J. "LC-MS/MS determination of 2-(4-((2-(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl)-2-oxoethylamino)-4-methyl-1-piperidinyl)-4-pyridinecarboxylic acid (ABT-279) in dog plasma with high-throughput protein precipitation sample preparation." Biomedical chromatography 21.11 (2007): 1118-1126.
description	12.	Maini, F. "The growing world of crystal forms." Chemical communications 46.34 (2010): 6232-42.
description	13.	Tabatabay, C. "Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester)." International Journal of Pharmaceutics 185.2 (1999): 189-198.
description	14.	Bond, Andrew D. "Polymorphism in molecular crystals." Current opinion in solid state & materials science 13.3-4 (2009): 91-97.
description	15.	Panina, N. "Polymorph prediction of organic pigments." Dyes and pigments 79.2 (2008): 183-192.
description	16.	Nazir, U. "A new triclinic polymorph of 4-n-hexyloxybenzoic acid." Acta crystallographica. Section E, Structure reports online 63 (2007).
description	17.	Cuppen, HM. "Sensitivity of morphology prediction to the force field: Paracetamol as an example." Crystal growth & design 4.6 (2004): 1341-1349.
description	18.	Maile, Frank J. "Effect pigments—past, present and future." Progress in organic coatings 54.3 (2005): 150-163.
description	19.	Kuhn, P. "The genesis of high-throughput structure-based drug discovery using protein crystallography." Current opinion in chemical biology 6.5 (2002): 704-710.
description	20.	Ho, M D. "Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection." Nature 373.6510 (1995): 123-126.